PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
19-Nov-2020 PAION REPORTS POSITIVE REMIMAZOLAM TOPLINE DATA IN EU PHASE III TRIAL IN GENERAL ANESTHESIA PAION AG
19-Nov-2020 INITIATE CONSULTANCY APPOINT ANDREW MUMFORD AS MANAGING DIRECTOR Initiate Consultancy
19-Nov-2020 New docking feature and improved search methods released in V10.6 of Spark scaffold hopping and bioisostere replacement software Cresset
19-Nov-2020 European Commission approves Sanofi Pasteur’s innovative Quadrivalent Recombinant Influenza Vaccine, Supemtek®▼, for the prevention of influenza in adults aged 18 years and older Sanofi
19-Nov-2020 OPEN Health Group Appoints New Leadership OPEN Health Group
19-Nov-2020 RedHill Biopharma to Present at German Equity Forum 2020 RedHill Biopharma
19-Nov-2020 Myricx Pharma Launches with £4.5M Financing to Progress its Novel NMT inhibitors in Cancer Myricx Pharma
19-Nov-2020 Lead Pharma enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases Lead Pharma
19-Nov-2020 Avantor® Opens New Biorepository Facility in Europe to Support Growing Demand for Scientific Research and Clinical Trial Sample Storage Avantor and Financial News
19-Nov-2020 Syngene and Deerfield Discovery and Development (3DC) sign 5-year strategic collaboration Syngene International
19-Nov-2020 One week to go Webinar on Cost-efficient and Green Manufacturing of Peptides thanks to Molecular Hiving™ Technology  SMi Group
19-Nov-2020 Leading Generic Drug Makers Unite to Pledge Capacity for Developing and Delivering Affordable COVID-19 Interventions as Pandemic Intensifies The Medicines Patent Pool (MPP)
19-Nov-2020 European Commission approves Supemtek® (quadrivalent recombinant influenza vaccine) for the prevention of influenza in adults aged 18 years and older Sanofi
19-Nov-2020 VFMCRP and Fresenius Kabi expand collaboration in nephrology in China with Veltassa® agreement Vifor Pharma
19-Nov-2020 COVID-19: Treatment for the Most Severely Affected Patients - After Promising Results in Named Patient Use - Clinical Trial with FX06 Starts in France B3C newswire
19-Nov-2020 EVOTEC PRESENTS GROWTH DRIVERS OF 'AUTOBAHN TO CURES' AT CAPITAL MARKETS DAY Evotec SE
19-Nov-2020 Vivoryon Therapeutics AG: Vivoryon Therapeutics AG to Publish its Third Quarter 2020 Business Update on November 26, 2020 Vivoryon Therapeutics AG
19-Nov-2020 INEX Innovate's iGene Laboratory announces new personalised medicine genotyping analysis project with Eli Lilly and Company's research unit Lilly Centre for Clinical Pharmacology INEX Innovate
18-Nov-2020 Flu Vaccinations For Seniors Are More Important Than Ever Conviva Care Centers
18-Nov-2020 LILLY’S EMGALITY® ▼(GALCANEZUMAB) RECEIVES A POSITIVE RECOMMENDATION FROM NICE FOR THE PREVENTION OF EPISODIC AND CHRONIC MIGRAINE Eli Lilly and Company